01 January 2008
The protective effect of resveratrol on the intestinal mucosal barrier in rats with severe acute pancreatitis
Rajiv Kumar JhaBCDEF, Ma Qing YongACDEG, Sha Huan ChenABCDEFGMed Sci Monit 2008; 14(1): BR14-19 :: ID: 636055
Abstract
Background
Severe acute pancreatitis (SAP) can result in intestinal mucosal barrier (IMB) dysfunction. The aim of this study is to demonstrate the protective effect of resveratrol (RES) on the IMB in rats with SAP.
Material and Method
Fifty-four male Sprague-Dawley (SD) rats were randomly divided into three equal groups: a sham-operated group (SO), a severe acute pancreatitis group (SAP), and a resveratrol-treated group (RES), each group containing 6 rats which were evaluated at 3, 6, and 12 h. Serum endotoxin levels were determined by turbidimetry. The apoptosis rate of intestinal mucosal cells was detected by using the TUNEL method and the expressions of the apoptosis-related proteins Bcl-2 and Bax were observed using an immunohistochemical technique.
Results
The serum endotoxin levels were significantly higher in the SAP group than in the SO group (P<0.05). The endotoxin levels of the RES group were lower than those of the SAP group at all the time-points (P<0.05). In the SAP group, pancreatic and intestinal mucosal congestion, edema, and inflammatory cell infiltration were apparent. In the RES group, pancreatic and intestinal morphological changes were alleviated at all time-points. The apoptotic cell index of the mucosal cells in the RES group was lower than that of the SAP group (P<0.05). In comparison with the SAP group, the RES group's expression of Bcl-2 increased and that of Bax decreased significantly (P<0.05).
Conclusions
An increase in intestinal mucosal cell apoptosis is involved in the intestinal mucosal dysfunction of SAP rats. Resveratrol could decrease endotoxin translocation and protect IMB function.
Keywords: Stilbenes - pharmacology, Proto-Oncogene Proteins c-bcl-2 - metabolism, Pancreas - pathology, Pancreatitis - physiopathology, Intestinal Mucosa - physiopathology, bcl-2-Associated X Protein - metabolism, Endotoxins - blood
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952